Showing results (561-570 of 869) with videos related to
Sort By:
Pageof 87
Journal of Alzheimer'S Disease : JAD|April 11, 2022
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic CohortNicola Girtler, Andrea Chincarini, Andrea Brugnolo, et al.Haematologica|October 4, 2017
Steroid treatment of acute graft-versus-host disease grade I: a randomized trialAndrea Bacigalupo, Giuseppe Milone, Alessandra Cupri, et al.JAMA Neurology|September 14, 2020
Association of Pregnancy With the Onset of Clinically Isolated SyndromeAi-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, et al.International Journal of MS Care|January 24, 2014
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010Stuart D Cook, Suhayl Dhib-Jalbut, Peter Dowling, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 19, 2024
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase RegistryAlessio Signori, Marta Ponzano, Tomas Kalincik, et al.Archives of Neurology|September 10, 2008
Reproducibility of optical coherence tomography in multiple sclerosisDeanna Cettomai, Mathew Pulicken, Eliza Gordon-Lipkin, et al.Lancet (London, England)|February 11, 2014
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialAndrew S C Rice, Robert H Dworkin, Tom D McCarthy, et al.Multiple Sclerosis and Related Disorders|February 7, 2020
Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QDGary Cutter, Antonella Veneziano, Augusto Grinspan, et al.The New England Journal of Medicine|February 14, 2024
Inhibition of CD40L with Frexalimab in Multiple SclerosisPatrick Vermersch, Cristina Granziera, Yang Mao-Draayer, et al.Contemporary Clinical Trials|April 26, 2019
Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple SclerosisRobert W Motl, Deborah Backus, Whitney N Neal, et al.Pageof 87